z-logo
open-access-imgOpen Access
Development of a Cannabinoid-Based Photoaffinity Probe to Determine the Δ8/9-Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells
Author(s) -
Marjolein Soethoudt,
Georgios Alachouzos,
Eva J. van Rooden,
María Dolores Moya-Garzón,
Richard J. B. H. N. van den Berg,
Laura H. Heitman,
Mario van der Stelt
Publication year - 2018
Publication title -
cannabis and cannabinoid research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.156
H-Index - 17
eISSN - 2578-5125
pISSN - 2378-8763
DOI - 10.1089/can.2018.0003
Subject(s) - photoaffinity labeling , diazirine , cannabinoid , chemistry , identification (biology) , receptor , delta 9 tetrahydrocannabinol , computational biology , cannabinoid receptor , click chemistry , pharmacology , combinatorial chemistry , biochemistry , biology , antagonist , botany
Δ 9 -Tetrahydrocannabinol (THC), the principle psychoactive ingredient in Cannabis , is widely used for its therapeutic effects in a large variety of diseases, but it also has numerous neurological side effects. The cannabinoid receptors (CBRs) are responsible to a large extent for these, but not all biological responses are mediated via the CBRs. Objectives: The identification of additional target proteins of THC to enable a better understanding of the (adverse) physiological effects of THC. Methods: In this study, a chemical proteomics approach using a two-step photoaffinity probe is applied to identify potential proteins that may interact with THC. Results: Photoaffinity probe 1 , containing a diazirine as a photocrosslinker, and a terminal alkyne as a ligation handle, was synthesized in 14 steps. It demonstrated high affinity for both CBRs. Subsequently, two-step photoaffinity labeling in neuroblastoma cells led to identification of four potential novel protein targets of THC. The identification of these putative protein hits is a first step towards a better understanding of the protein interaction profile of THC, which could ultimately lead to the development of novel therapeutics based on THC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom